Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Dr Reddys Laboratories (RDY) over the last 17 years, with Q4 2025 value amounting to $458.1 million.

  • Dr Reddys Laboratories' Accounts Payables changed N/A to $458.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $458.1 million, marking a year-over-year change of. This contributed to the annual value of $417.0 million for FY2025, which is 1239.89% up from last year.
  • Per Dr Reddys Laboratories' latest filing, its Accounts Payables stood at $458.1 million for Q4 2025.
  • Over the past 5 years, Dr Reddys Laboratories' Accounts Payables peaked at $461.3 million during Q3 2025, and registered a low of -$29.6 million during Q3 2022.
  • Over the past 5 years, Dr Reddys Laboratories' median Accounts Payables value was $323.7 million (recorded in 2021), while the average stood at $255.9 million.
  • As far as peak fluctuations go, Dr Reddys Laboratories' Accounts Payables tumbled by 14437.7% in 2022, and later skyrocketed by 85121.79% in 2025.
  • Quarter analysis of 5 years shows Dr Reddys Laboratories' Accounts Payables stood at $326.9 million in 2021, then fell by 3.04% to $317.0 million in 2022, then tumbled by 82.57% to $55.3 million in 2023, then decreased by 12.24% to $48.5 million in 2024, then surged by 844.58% to $458.1 million in 2025.
  • Its Accounts Payables stands at $458.1 million for Q4 2025, versus $461.3 million for Q3 2025 and $72.5 million for Q2 2025.